Hematogones in acute leukemia during and after therapy

Leukemia and Lymphoma

Volumn 49, Issue 10, 2008, Pages 1935-1944

  Babušíková, Ol'ga ^a   Železníková, Tatiana ^a   Kirschnerová, Gabriela ^a   Kankuri, Esko ^b,c  

^a CANCER RESEARCH INSTITUTE   (Slovakia)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Acute leukemia; Benign B lymphocyte precursors; Hematogones; Minimal residual disease; Multiparameter flow cytometry

Indexed keywords

ANTHRACYCLINE; CYTARABINE;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; B CELL LEUKEMIA; B LYMPHOCYTE; BONE MARROW BIOPSY; CELL MATURATION; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEMATOGONE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; INCIDENCE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; REGENERATION; T CELL LEUKEMIA;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; BONE MARROW; BONE MARROW EXAMINATION; CHILD; CHILD, PRESCHOOL; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; INFANT; INFANT, NEWBORN; LEUKEMIA; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REGENERATION;

EID: 55049128877     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701817274     Document Type: Conference Paper

References (21)

1. Loken, M. R., Shah, V. O., Dattilio, K. L. and Civin, C. I. (1987) Flow cytometric analysis of human bone marrow. II. Normal B-lymphocyte development. Blood, 70, pp. 1316-1324.
2. Zamir, E., Geiger, B., Cohen, N., Kam, Z. and Katz, B-Z (2005) Resolving and classifying haematopoietic bone-marrow cell populations by multi-dimensional analysis of flow-cytometry data. Br J Haematol, 129, pp. 420-431.
3. Campana, D. (2004) Minimal residual disease studies in acute leukemia. Am J Clin Pathol, 122, pp. S47-S57.
4. Lucio, P., Parreira, A., van den Beemd, M W, van Lochem, E. G., van Wering, E. R. Baars, E. et al. (1999) Flow cytometric analysis of normal B cell differentiation: A frame of reference for the detection of minimal residual disease in precursor-B-ALL. Leukemia, 13, pp. 419-427.
5. McKenna, R. W., Asplund, S. L. and Kroft, S. H. (2004) Immunophenotypic analysis of hematogones (B-lymphocyte precursors) and neoplastic lymphoblasts by 4-color flow cytometry. Leuk Lymphoma, 45, pp. 277-285.
6. Basso, G., Buldini, B., de Zen, L. and Orfao, A. (2001) New methodological approaches for immunophenotyping acute leukemias. Haematology, 86, pp. 675-692.
7. Rimsza, L. M., Douglas, V. K., Tighe, P., Saxonhause, M. A., Calhoun, D. A. Christensen, R. D. et al. (2004) Benign B-cell precursors (hematogones) are the predominant lymphoid population in the bone marrow of preterm infants. Biol Neonate, 86, pp. 247-253.
8. Rossi, M ID, Yokota, T., Medina, K. L., Garrett, K. P., Comp, P. C. Schipul Jr, A. H. et al. (2003) B lymphopoiesis is active throughout human life, but there are developmental age-related changes. Blood, 101, pp. 576-584.
9. van Lochem, E. G., Wiegers, Y. M., van dem Beemd, R, Hahlend, K., van Dongen, J JM and Hooijkaas, H. (2000) Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy. Leukemia, 14, pp. 688-695.
10. McKenna, R. W., Washington, L. T., Aquino, D. B., Picker, L. J. and Kroft, S. H. (2001) Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood, 98, pp. 2498-2507.
11. Swedmyr, B., Bentsson, M., Jakobsson, A., Simonsson, B., Oberg, G. and Tõtterman, T H (1991) Regeneration of CALLA (CD10+), and double-positive cells in the bone marrow and blood after autologous bone marrow transplantation. Eur J Haematol, 46, pp. 146-151.
12. Babusikova, O., Zeleznikova, T., Mlcakova, A., Kusenda, J. and Stevulova, L. (2005) The knowledge on the 3rd type hematogones' could contribute to more precise detection of small numbers of precursors B-acute lymphoblastic leukemia. Neoplasma, 52, pp. 502-509.
13. van Lochem, E. G., van der Velden, V HJ, Wind, H. K., te Marvelde, J G, Westerdaal, N AC and van Dongen, J JM (2004) Immunophenotyping differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts. Cytometry: Part B, 60, pp. 1-13.
14. Zeleznikova, T. and Babusikova, O. (2006) The impact of cell heterogeneity and immunophenotyping changes on monitoring minimal residual disease in acute myeloid leukemia. Neoplasma, 53, pp. 500-506.
15. Babusikova, O. and Zeleznikova, T. (2004) The value of multiparameter flow cytometry of cerebrospinal fluid involved by leukemia/lymphoma cells. Neoplasma, 51, pp. 345-352.
16. Zipf, T. F. and Johnston, D. A. (2003) Leukemia and Lymphoma: Detection of Minimal Residual Disease, pp. 119-162. Humana Press, New Jersey
17. San Miguel, J F, Martinez, A., Macedo, A., Vidriales, M. B., Lopez-Berges, C. Gonzales, M. et al. (1997) Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients. Blood, 90, pp. 2465-2470.
18. van Wering, E. R., van der Linden-Schrever, B. E., Szcepanski, T., Willemse, M. J., Baars, E. A. Hanne, M. et al. (2000) Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: Implications for monitoring of minimal residual disease. Br J Haematol, 110, pp. 139-146.
19. Vargas, S. O., Hasegawa, S. L. and Dorfman, D. M. (1999) Hematogones as an internal control in flow cytometric analysis of suspected acute lymphoblastic leukemia. Pediatr Dev Pathol, 2, pp. 371-376.
20. Kroft, S. H., Asplund, S. L., McKenna, R. W. and Karadikar, N. J. (2004) Haematogones in the peripheral blood of adults: A four-colour flow cytometry study of 102 patients. Br J Haematol, 126, pp. 209-212.
21. Zeleznikova, T., Stevulova, L., Kovarikova, A. and Babusikova, O. (2007) Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia. Neoplasma, 54, pp. 471-477.